Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunther Hartmann

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Plos One|September 13, 2012
Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptidesRudolf L Riepl, Rainald Fischer, Hubert Hautmann, et al.
Biomedicines|September 27, 2025
Expression Analysis of let-7a-5p and miR-21-3p in Extracellular Vesicles Derived from Serum of NSCLC PatientsDian Jamel Salih, Katrin S Reiners, Domenico Loizzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2003
Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cellsMiren Kerkmann, Simon Rothenfusser, Veit Hornung, et al.
Immunity|September 3, 2013
Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensingNadine Gehrke, Christina Mertens, Thomas Zillinger, et al.
JMIR Research Protocols|June 10, 2026
Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus StudyKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 17, 2017
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancersRamona C Dolscheid-Pommerich, Mignon Keyver-Paik, Thomas Hecking, et al.
European Journal of Immunology|January 31, 2003
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyKlaus Heckelsmiller, Sebastian Beck, Katharina Rall, et al.
Plos One|August 14, 2013
A human in vitro whole blood assay to predict the systemic cytokine response to therapeutic oligonucleotides including siRNAChristoph Coch, Christian Lück, Anna Schwickart, et al.
Clinical Drug Investigation|July 17, 2023
Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature ReviewKatharina Karsten Dafonte, Lisa Weber, Florian Chmielewski, et al.
International Journal of Cancer|September 20, 2018
Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity toward autologous melanoma cellsJuliane Daßler-Plenker, Annette Paschen, Bastian Putschli, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Plos One|September 13, 2012
Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptidesRudolf L Riepl, Rainald Fischer, Hubert Hautmann, et al.
Biomedicines|September 27, 2025
Expression Analysis of let-7a-5p and miR-21-3p in Extracellular Vesicles Derived from Serum of NSCLC PatientsDian Jamel Salih, Katrin S Reiners, Domenico Loizzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2003
Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cellsMiren Kerkmann, Simon Rothenfusser, Veit Hornung, et al.
Immunity|September 3, 2013
Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensingNadine Gehrke, Christina Mertens, Thomas Zillinger, et al.
JMIR Research Protocols|June 10, 2026
Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus StudyKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 17, 2017
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancersRamona C Dolscheid-Pommerich, Mignon Keyver-Paik, Thomas Hecking, et al.
European Journal of Immunology|January 31, 2003
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyKlaus Heckelsmiller, Sebastian Beck, Katharina Rall, et al.
Plos One|August 14, 2013
A human in vitro whole blood assay to predict the systemic cytokine response to therapeutic oligonucleotides including siRNAChristoph Coch, Christian Lück, Anna Schwickart, et al.
Clinical Drug Investigation|July 17, 2023
Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature ReviewKatharina Karsten Dafonte, Lisa Weber, Florian Chmielewski, et al.
International Journal of Cancer|September 20, 2018
Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity toward autologous melanoma cellsJuliane Daßler-Plenker, Annette Paschen, Bastian Putschli, et al.
Pageof 20